STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
177
13F, latest reported quarter
Conversions, 180 days
5
Codes C/M, not in net · $239.0K priced
What the filings say about AEHR
Insiders, 180 days
-$19.9M net sold
10 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$17.3M
13 notices
Aehr Test Systems insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AEHR TEST SYSTEMS insiders sold a net $19.9M of stock across 211 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Aug 14, 2026.
The trade is 2.1% of the 186,232 shares held after it.
8 other insiders sold within 30 days.
177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec VP of Sales & Mktg. ROGERS VERNON sold about $574.2K of AEHR on Aug 17, 2026; 8 other insiders sold within 30 days and 177 funds added in the latest 13F quarter.
27 earlier Form 4 trades (code P or S) here by this insider (27 sales), the last on Aug 12, 2026.
The trade is 1.6% of the 381,989 shares held after it.
8 other insiders sold within 30 days.
177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director POSEDEL RHEA J sold about $836.2K of AEHR on Aug 14, 2026; 8 other insiders sold within 30 days and 177 funds added in the latest 13F quarter.
23 earlier Form 4 trades (code P or S) here by this insider (2 buys, 21 sales), the last on Aug 4, 2026.
-23.3% median (-23.3% mean) 90-day return after 2 previous buys.
The trade is 4.1% of the 140,667 shares held after it.
8 other insiders sold within 30 days.
177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SLAYEN HOWARD T sold about $758.3K of AEHR on Aug 14, 2026; 8 other insiders sold within 30 days and 177 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Apr 21, 2026.
The trade is 0.5% of the 191,226 shares held after it.
8 other insiders sold within 30 days.
177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec VP of Sales & Mktg. ROGERS VERNON sold about $134.0K of AEHR on Aug 14, 2026; 8 other insiders sold within 30 days and 177 funds added in the latest 13F quarter.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Apr 21, 2026.
The trade is 0.5% of the 190,226 shares held after it.
8 other insiders sold within 30 days.
177 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Exec VP of Sales & Mktg. ROGERS VERNON sold about $139.0K of AEHR on Aug 14, 2026; 8 other insiders sold within 30 days and 177 funds added in the latest 13F quarter.
211 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AEHR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
ROGERS VERNON
Filed 2026-08-17
$574.2K
POSEDEL RHEA J
Filed 2026-08-14
$836.2K
SLAYEN HOWARD T
Filed 2026-08-14
$753.9K
ROGERS VERNON
Filed 2026-08-14
$273.0K
SALAMONE ALBERTO
Filed 2026-08-13
$1.2M
AEHR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco Dorsey Wright Technology Momentum ETF
$17.4M position · as of 2026-07-31
3.0%
Berkshire Focus Fund
$13.7M position · as of 2026-06-30
3.0%
Lord Abbett Micro-Cap Growth Fund
$5.5M position · as of 2026-07-31
2.6%
RiverPark/Next Century Growth Fund
$252.6K position · as of 2026-06-30
2.1%
1290 VT Micro Cap Portfolio
$3.3M position · as of 2026-06-30
1.5%
Corgi Lithography & Semiconductor Photonics ETF
$4.4M position · as of 2026-06-30
1.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Erickson
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.2M
$22.4M
$1.2M
+180%
n/a
2024
$3.4M
$2.3M
$1.2M
-71%
n/a
2023
$1.4M
-$927.7K
$958.2K
-65%
n/a
2022
$1.7M
$6.9M
$720.3K
+294%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $19.9M sold by insiders over 180 days, 177 funds added last quarter, $17.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$50.0M
four quarters, 2025-05-31 to 2026-05-29
Revenue, TTM AEHR
FY May 2026
$50.0M
FY May 2025
n/a
FY May 2024
$66.2M
FY May 2023
$65.0M
FY May 2022
$50.8M
May 2026
$18.8M
Feb 2026
$10.3M
Nov 2025
$9.9M
Aug 2025
$11.0M
May 2025
$14.1M
Feb 2025
$18.3M
Nov 2024
$13.5M
Aug 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
-14.3%
net income over revenue, 2025-05-31 to 2026-05-29
Net margin, TTM AEHR
FY May 2026
-14.3%
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
+22.4%
FY May 2022
+18.6%
May 2026
+7.4%
Feb 2026
-31.1%
Nov 2025
-32.7%
Aug 2025
-19.0%
May 2025
-20.6%
Feb 2025
-3.5%
Nov 2024
-7.6%
Aug 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$5.4M
operating cash flow minus capex, 2025-05-31 to 2026-05-29
Free cash flow, TTM AEHR
FY May 2026
-$5.4M
FY May 2025
-$12.4M
FY May 2024
$1.0M
FY May 2023
$8.6M
FY May 2022
$1.1M
May 2026
$1.7M
Feb 2026
-$3.8M
Nov 2025
-$1.6M
Aug 2025
-$1.7M
May 2025
-$5.1M
Feb 2025
-$3.3M
Nov 2024
-$6.2M
Aug 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2021-05-31 (60 months older than the period end) plus current 2022-05-31 (48 months older than the period end); equity 2026-05-29
Debt to equity AEHR
FY May 2026
0.00x
FY May 2025
0.00x
FY May 2024
0.00x
FY May 2023
0.00x
FY May 2022
0.00x
May 2026
0.00x
Feb 2026
0.00x
Nov 2025
0.00x
Aug 2025
0.00x
May 2025
0.00x
Feb 2025
0.00x
Nov 2024
0.00x
Aug 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt AEHR
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
n/a
FY May 2022
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-4.2%
TTM net income over average of 2025-05-30 and 2026-05-29
Return on equity AEHR
FY May 2026
-4.2%
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
+23.0%
FY May 2022
+30.3%
May 2026
-4.2%
Feb 2026
-8.7%
Nov 2025
-7.0%
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-3.6%
TTM net income over average of 2025-05-30 and 2026-05-29
Return on assets AEHR
FY May 2026
-3.6%
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
+18.1%
FY May 2022
+22.5%
May 2026
-3.6%
Feb 2026
-7.5%
Nov 2025
-6.1%
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital AEHR
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
n/a
FY May 2023
+41.0%
FY May 2022
+58.6%
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-7.8%
operating income (EBIT proxy) over average of 2025-05-30 and 2026-05-29 minus current liabilities
Return on capital employed AEHR
FY May 2026
-7.8%
FY May 2025
n/a
FY May 2024
+10.1%
FY May 2023
+20.1%
FY May 2022
+24.4%
May 2026
-7.8%
Feb 2026
-11.6%
Nov 2025
-9.6%
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
-0.8%
Aug 2024
+5.7%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing AEHR
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
10.28x
FY May 2023
66.04x
FY May 2022
24.65x
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.0B
market value at close 2026-10-27 on 2026-07-20 shares, plus long-term 2021-05-31 (60 months older than the period end) plus current 2022-05-31 (48 months older than the period end), minus cash 2026-05-29
Enterprise value AEHR
FY May 2026
$2.8B
FY May 2025
$259.5M
FY May 2024
$283.6M
FY May 2023
$905.7M
FY May 2022
$194.1M
May 2026
$2.8B
Feb 2026
$1.1B
Nov 2025
$658.4M
Aug 2025
$723.7M
May 2025
$259.5M
Feb 2025
$257.0M
Nov 2024
$320.1M
Aug 2024
$403.4M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-0.3%
TTM free cash flow over market value at close 2026-10-27
FCF yield AEHR
FY May 2026
-0.2%
FY May 2025
-4.4%
FY May 2024
+0.3%
FY May 2023
+0.9%
FY May 2022
+0.5%
May 2026
-0.2%
Feb 2026
-1.1%
Nov 2025
-1.7%
Aug 2025
-2.2%
May 2025
-4.4%
Feb 2025
-2.1%
Nov 2024
-1.7%
Aug 2024
-0.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing AEHR
FY May 2026
n/a
FY May 2025
n/a
FY May 2024
0.08x
FY May 2023
1.40x
FY May 2022
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
Aug 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AEHR ranks highest on financial health (99th percentile) and institutional and government (54th), and lowest on insider conviction (7th), among Industrials peers.
Profitability
23
Inputs
Return on equity-4.2% · 22 pct, sector of 198
Return on assets-3.6% · 26 pct, sector of 224
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-7.8% · 21 pct, sector of 195
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 214
Cash flow to debtno debt to cover
Growth
12
Inputs
Revenue growth, YoY-15.2% · 9 pct, sector of 254
Backlog growth, YoY-24.4% · 15 pct, sector of 89
Insider conviction
7
Inputs
Net Form 4 buying (codes P and S), 180d-$19.9M · 14 pct, sector of 170
Insider buyers, 180d0 · 0 pct, sector of 172
Institutional and government
54
Inputs
Funds adding, latest quarter177 · 54 pct, sector of 201
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
53
Inputs
Short interest, % of float+16.7% · 8 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+10.9% · 50 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AEHR filings, in plain words
Are Aehr Test Systems insiders buying or selling AEHR?
In the 180 days to 2026-10-28, Aehr Test Systems insiders were net sellers, a net $19.9M across purchases and sales reported on Form 4, by 10 sellers.
Are there planned insider sales of AEHR?
Yes. 13 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $17.3M of stock; the latest, by ROGERS VERNON, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-28, Aehr Test Systems insiders were net sellers of AEHR, a net $19.9M across purchases and sales reported on Form 4 by 10 sellers. None of the 22 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 13 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $17.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.